openPR Logo
Press release

Huateng Pharma Develops Intermediates of Semaglutide For TD2

Huateng Pharma Develops Intermediates of Semaglutide For TD2

According to the latest IDF Diabetes map, the global prevalence of diabetes reached 10.5% in 2021, with 537 million adults living with diabetes. China has become a disaster zone for diabetes, with the largest number of adults with diabetes in the world. In the past 10 years (2011-2021), the number of people with diabetes in China increased from 90 million to 140 million, an increase of 56%. The total number of diabetes patients in China will continue to increase in the next 20 years, and is expected to reach 175 million by 2045.

Having diabetes in such a large number of people is a huge health hazard. At the moment when the novel coronavirus is raging around the world, the mortality rate of the novel coronavirus pneumonia in patients with diabetes is significantly higher than that in patients without diabetes. According to the statistics of the deaths of COVID-19 patients in China by the Chinese Center for Disease Control and Prevention , the mortality rate of COVID-19 patients with diabetes underlying diseases is 7.3%, which is 7 times higher than that of patients without any underlying diseases.

In order to improve public health and reduce mortality, it is urgent to effectively manage blood glucose and improve the risk factors of cardiovascular diseases, but the current situation of diabetes management is not optimistic.

Diabetes and cardiovascular diseases are the leading causes of death from chronic noncommunicable diseases in middle-aged and older people. China has been hit hard by the global diabetes pandemic, with an estimated 140 million people living with the disease. The number of diabetic patients in China is huge and the situation is difficult. In addition to the low rate of blood glucose control, many patients are complicated with obesity, hypertension, hyperlipidemia and other high-risk factors of cardiovascular diseases. Therefore, patients need to take a lot of drugs, which seriously affects their quality of life.

The emergence of semaglutide, a new GLP-1RA weekly preparation, has brought hope to patients with diabetes. It can be multi-pranged -- it can significantly reduce body weight, improve blood pressure and lipid profile while lowering glucose. It is because of the improvement of multiple risk factors that Semaglutide, unsurprisingly, showed a significant reduction in the risk of cardiovascular events and became the only weekly GLP-1RA preparation approved for cardiovascular indications in China. Semaglutide, a one-drug, once-a-week injection, has also greatly increased patient satisfaction with treatment.

Huateng Pharma is expert in manufacturing and development of pharmaceutical intermediates in its ultra-modern state of art facilities. We can provide pharmaceutical intermediates of semaglutide, such as CH2COOH-PEG2-NH2.HCl (CAS NO.:134979-01-4), Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH (CAS NO.:1662688-20-1), (S)-22-(Tert-butoxycarbonyl)-43,43-dimethyl-10,19,24,41-tetraoxo-3,6,12,15,42-pentaoxa-9,18,23-triazatetratetracontanoic acid (CAS NO.1118767-16-0), Boc-NH-PEG2-CH2COOH (CAS NO.:108466-89-3), Fmoc-NH-PEG2-CH2COOH (CAS NO.:166108-71-0), NH2-PEG2-CH2COOH (CAS NO.:134978-97-5), 17-amino-10-oxo-3,6,12,15-tetraoxa-9-azaheptadecan-1-oic acid (CAS NO.:1143516-05-5) and Octadecanedioic acid (CAS NO.:871-70-5). For more information, please email us at sales@huatengusa.com.

Company: Hunan HuaTeng Pharmaceutical Co., Ltd.
Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, P.R. China.
ZIP Code: 410006
Email: sales@huatengusa.com
Website: https://en.huatengsci.com/

Huateng Pharma is a leading and professional manufacturer which can provide pharmaceutical intermediates, PEG derivatives, biochemical reagents, APIs, Vitamin D Derivatives and so on. We have a 34,000 square meter manufacturing site with advanced design concept of intelligent manufacturing, which can realize the integration of the production process and accomplish the complete transformation of lab scale - pilot plant - large-scale commercial production, with an annual capacity of more than 1 billion RMB.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Huateng Pharma Develops Intermediates of Semaglutide For TD2 here

News-ID: 2777598 • Views: 364

More Releases from Hunan Huateng Pharmaceutical Co. Ltd.

Huateng Pharma Develops Systemic Antiparasitic Agent Fluralaner
Fluralaner is a systemic insecticide and acaricide that can be administered orally or topically. Bravecto is the trade name. The U.S. Food and Drug Administration (FDA) approved it for flea treatment in dogs under the trade name Bravecto in May 2014 and for topical treatment in cats in November 2019. Fluralaner is a novel isooxazoline broad-spectrum insecticide that acts on γ-aminobutyric acid (GABA) receptors and has good activity against ticks, fleas,
Huateng Pharma Develops Intermediates of Carfilzomib For Multiple Myeloma
Carfilzomib, a proteasome inhibitor, is indicated for the treatment of patients with multiple myeloma. Multiple myeloma (multiple myeloma, MM) is a malignant tumor originating from the B cell lineage, characterized by the clonal proliferation of malignant plasma cells in the bone marrow microenvironment, causing fractures and bone marrow failure, and is the second most common blood system disease in the world Tumors cannot be cured by traditional chemotherapy regimens. Bortezomib is the
The Future of Treatment For Type 2 Diabetes
Although the treatment of type 2 diabetes (T2DM) has made impressive progress in the past few decades, researchers are constantly searching for new treatments. How to better control blood glucose and reduce diabetes-related complications has become a hot topic in the field of T2DM research. Previously, The Lancet Diabetes Endocrinology published an in-depth review detailing novel therapeutic targets for T2DM, mechanisms of drug action, and corresponding hypoglycemic efficacy. It involves innovation
Huateng Pharma Supplies PEG Products As Ingredients In mRNA COVID-19 Vaccines
Since the COVID-19 epidemic, Pfizer and Moderna have used mRNA technology in a vaccine to help humans fight COVID-19. While mRNA technology is new to the public, the research has been around since the early 1990s. What is an mRNA vaccine? An mRNA vaccine is a vaccine that uses a molecular copy of messenger RNA (mRNA) to generate an immune response. Such vaccines deliver mRNA molecules into the body's immune cells, where

All 5 Releases


More Releases for China

Forehead Thermometer Market Analysis (2019- 2025)| Microlife (China), Radiant (C …
This research study is one of the most detailed and accurate ones that solely focus on the global Forehead Thermometer market. It sheds light on critical factors that impact the growth of the global Forehead Thermometer market on several fronts. Market participants can use the report to gain a sound understanding of the competitive landscape and strategies adopted by leading players of the global Forehead Thermometer market. The authors of
Analysis of the Global And China Handheld Transceiver Market-Top players BAOFENG …
The Global And China Handheld Transceiver Market is a professional report which provides thorough knowledge along with complete information perta¬ining to the Handheld Transceiver industry propos classifications, definitions, applications, industry chain summary, industry policies in addition to plans, product specifications, manufacturing processes, cost structures, etc. Key Regions First-tier Cities • Beijing • Shanghai • Guangzhou • Shenzhen Free Sample PDF Copy of Handheld Transceiver Market research report @ https://www.qyresearchgroups.com/request-sample/453291 Report Includes:- This report focus Chinese market, it covers details as following: Key
Analysis of the Global And China Calculator Market-Top players Aurora(Taiwan, Ch …
The Global And China Calculator Market is a professional report which provides thorough knowledge along with complete information perta¬ining to the Calculator industry propos classifications, definitions, applications, industry chain summary, industry policies in addition to plans, product specifications, manufacturing processes, cost structures, etc. Key Regions First-tier Cities • Beijing • Shanghai • Guangzhou • Shenzhen Free Sample PDF Copy of Calculator Market research report @ https://www.qyresearchgroups.com/request-sample/453273 Report Includes:- This report focus Chinese market, it covers details players regions product type and
Analysis of the Global And China Activity Tracker Market-Top MI(China), Huawei(C …
The Global And China Activity Tracker Market is a professional report which provides thorough knowledge along with complete information perta¬ining to the Activity Tracker industry propos classifications, definitions, applications, industry chain summary, industry policies in addition to plans, product specifications, manufacturing processes, cost structures, etc. Key Regions First-tier Cities • Beijing • Shanghai • Guangzhou • Shenzhen Free Sample PDF Copy of Activity Tracker Market research report @ https://www.qyresearchgroups.com/request-sample/453264 Report Includes:- This report focus Chinese market, it covers details players regions
Analysis of the Global And China Money Counter Market-Top players Deli(China) ,W …
The Global And China Money Counter Market is a professional report which provides thorough knowledge along with complete information perta¬ining to the Money Counter industry propos classifications, definitions, applications, industry chain summary, industry policies in addition to plans, product specifications, manufacturing processes, cost structures, etc. Key Regions First-tier Cities • Beijing • Shanghai • Guangzhou • Shenzhen Free Sample PDF Copy of Money Counter Market research report @ https://www.qyresearchgroups.com/request-sample/453304 Report Includes:- This report focus Chinese market, it covers details as following: Key
Global Color Steel Tile Market 2017 - South China, East China, Southwest China, …
Color Steel Tile Market Research Report A market study based on the " Color Steel Tile Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Color Steel Tile Market 2017’. The research report analyses the historical as well as present performance of the worldwide Color Steel Tile industry, and makes predictions on the future status of Color Steel Tile market on the basis